HC-7366

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameHC-7366
Drug Alias Nameimmediate release capsule formulation of HC-7366 potassium salt monohydrate (HC-7366-K) (HiberCell)HC-7366
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic translation initiation factor 2-alpha kinase 4 activators
TargetsEukaryotic translation initiation factor 2-alpha kinase 4
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsKidney Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHiberCell Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer CenterHiberCell Inc
Inactive CompaniesN/A
Active IndicationsKidney NeoplasmsCarcinoma, Renal CellLeukemia, Myeloid, Acute
Inactive IndicationsSolid tumoursUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell Lung +[6] 

Other Information

ATC CodeN/A
Related LinksN/A